Sydney Knight, Rachel Swance, Emma A Bateman, Kristin K Clemens, Alexandra Papaioannou, Jamie L Fleet
{"title":"Post-Stroke Osteoporosis Screening: A Scoping Review.","authors":"Sydney Knight, Rachel Swance, Emma A Bateman, Kristin K Clemens, Alexandra Papaioannou, Jamie L Fleet","doi":"10.1159/000542924","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There are no specific screening recommendations for post-stroke osteoporosis despite evidence that people post-stroke are at heightened risk of fragility fractures. Our objective was to explore the extent of evidence and map the current literature available for osteoporosis screening in the post-stroke population.</p><p><strong>Methods: </strong>This scoping review searched for articles in Medline, Embase, and CINAHL databases published in English before May 2024, involving osteoporosis screening for adults after stroke. Title and abstract screening as well as full text review and data extraction was performed by two reviewers. Analysis of the studies is descriptive and narrative.</p><p><strong>Results: </strong>Eight articles met inclusion criteria: five published articles and three peer-reviewed conference abstracts. Three study designs were utilized: four cross-sectional studies, three cohort studies, and one survey. Four studies investigated post-stroke osteoporosis screening rates, two looked at screening pathways for post-stroke osteoporosis, and two assessed novel osteoporosis screening tools. No post-stroke osteoporosis screening guidelines were found. Across all included studies, reported screening rates for post-stroke osteoporosis were less than 10%.</p><p><strong>Conclusions: </strong>This scoping review emphasizes the need for osteoporosis screening guidelines and risk assessment tools specific to the post-stroke population.</p>","PeriodicalId":9683,"journal":{"name":"Cerebrovascular Diseases","volume":" ","pages":"1-15"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542924","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: There are no specific screening recommendations for post-stroke osteoporosis despite evidence that people post-stroke are at heightened risk of fragility fractures. Our objective was to explore the extent of evidence and map the current literature available for osteoporosis screening in the post-stroke population.
Methods: This scoping review searched for articles in Medline, Embase, and CINAHL databases published in English before May 2024, involving osteoporosis screening for adults after stroke. Title and abstract screening as well as full text review and data extraction was performed by two reviewers. Analysis of the studies is descriptive and narrative.
Results: Eight articles met inclusion criteria: five published articles and three peer-reviewed conference abstracts. Three study designs were utilized: four cross-sectional studies, three cohort studies, and one survey. Four studies investigated post-stroke osteoporosis screening rates, two looked at screening pathways for post-stroke osteoporosis, and two assessed novel osteoporosis screening tools. No post-stroke osteoporosis screening guidelines were found. Across all included studies, reported screening rates for post-stroke osteoporosis were less than 10%.
Conclusions: This scoping review emphasizes the need for osteoporosis screening guidelines and risk assessment tools specific to the post-stroke population.
期刊介绍:
A rapidly-growing field, stroke and cerebrovascular research is unique in that it involves a variety of specialties such as neurology, internal medicine, surgery, radiology, epidemiology, cardiology, hematology, psychology and rehabilitation. ''Cerebrovascular Diseases'' is an international forum which meets the growing need for sophisticated, up-to-date scientific information on clinical data, diagnostic testing, and therapeutic issues, dealing with all aspects of stroke and cerebrovascular diseases. It contains original contributions, reviews of selected topics and clinical investigative studies, recent meeting reports and work-in-progress as well as discussions on controversial issues. All aspects related to clinical advances are considered, while purely experimental work appears if directly relevant to clinical issues.